Beijing Inflama Lab
PrivateLast Round
Series B
Jul 3, 2026
Total Funding Raised
$97.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beijing Inflama Lab is a biotechnology company that develops revolutionary innovative drugs for the treatment of inflammation and tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Inflama Lab Comparables
Compare Beijing Inflama Lab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XtalPi | 78% | |
| DotBio | 77% | |
| Olatec Therapeutics | 73% | |
Beijing Inflama Lab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 3, 2026 | ||||
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 10, 2023 | ||||
| Angel | Jan 1, 2021 |
Beijing Inflama Lab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Angel, Series A |
| Beijing Chang Development | Series B, Angel, Series A |
| MSA Capital | Series A, Angel |
| China Reform Holdings Corporation Ltd. | Series B |
| China Reform Fund Management Co.,Ltd | Series B |
| 上海国投先导私募基金管理有限公司 | Series B |
| Frees Fund | Series B, Series A Extension, Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
Led by 上海国投先导私募基金管理有限公司 with participation from China Reform Fund Management Co.,Ltd.
Beijing Inflama Lab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Inflama Lab's valuation, stock price, and market status.